KLK3 and Familial prostate cancer: Approximately 71% (n = 10) of the 14 information materials contain statements reporting that PCa-specific mortality can be reduced through regular PSA testing (example: “PSA-based early detection and treatment of prostate cancer can theoretically reduce the mortality of prostate cancer”).